top of page
< Back

Risedronate

利塞膦酸

Mechanism of action:

Risedronate 是一種含氮雙磷酸鹽（nitrogen-containing bisphosphonate）衍生物。Risedronate 會選擇性結合於骨表面的羥磷灰石，特別集中在骨吸收活躍的部位。當破骨細胞（osteoclast）進行骨吸收時，risedronate 會隨骨基質被破骨細胞吞入細胞內。Risedronate 在破骨細胞內會抑制法尼基焦磷酸合酶（farnesyl pyrophosphate synthase），阻斷異戊二烯化（prenylation）所需的中間產物生成。當小型 GTP 結合蛋白（如 Ras、Rho、Rab）無法進行異戊二烯化（prenylation）時，破骨細胞的多種代謝會受到抑制，最終導致破骨細胞凋亡。

​Reference(s):

1. Russell RG et al. (2008). Mechanisms of action of bisphosphonates: similarities and differences and their potential influence on clinical efficacy. Osteoporos Int. 


2. Cremers S et al. (2019). Pharmacology of bisphosphonates. Br J Clin Pharmacol. 


3. Thompson Micromedex. (2004). Usp Vol I Drug Info Health Vol: Volume I (USP DI: v.1 Drug Information for the Health Care Professional) (24th ed., pp. 2475). Thompson PDR.

bottom of page